[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK612886D0 - Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne - Google Patents

Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne

Info

Publication number
DK612886D0
DK612886D0 DK612886A DK612886A DK612886D0 DK 612886 D0 DK612886 D0 DK 612886D0 DK 612886 A DK612886 A DK 612886A DK 612886 A DK612886 A DK 612886A DK 612886 D0 DK612886 D0 DK 612886D0
Authority
DK
Denmark
Prior art keywords
anisamids
intermediates
procedures
procedure
production
Prior art date
Application number
DK612886A
Other languages
English (en)
Other versions
DK612886A (da
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DK612886D0 publication Critical patent/DK612886D0/da
Publication of DK612886A publication Critical patent/DK612886A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK612886A 1985-12-19 1986-12-18 Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne DK612886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518829A FR2592042B1 (fr) 1985-12-19 1985-12-19 Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
DK612886D0 true DK612886D0 (da) 1986-12-18
DK612886A DK612886A (da) 1987-06-20

Family

ID=9325965

Family Applications (1)

Application Number Title Priority Date Filing Date
DK612886A DK612886A (da) 1985-12-19 1986-12-18 Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne

Country Status (37)

Country Link
US (2) US4835172A (da)
EP (1) EP0236646B1 (da)
JP (1) JPS62246553A (da)
KR (1) KR930004653B1 (da)
CN (1) CN1018454B (da)
AR (1) AR242193A1 (da)
AT (1) ATE57376T1 (da)
AU (1) AU586057B2 (da)
CA (2) CA1298301C (da)
CH (1) CH671396A5 (da)
CS (1) CS274285B2 (da)
DD (1) DD260495A5 (da)
DE (2) DE3674916D1 (da)
DK (1) DK612886A (da)
ES (1) ES2036178T3 (da)
FI (1) FI865190A (da)
FR (1) FR2592042B1 (da)
GB (1) GB2184723B (da)
GR (1) GR3002524T3 (da)
HU (1) HU196794B (da)
IE (1) IE59212B1 (da)
IL (1) IL81010A (da)
IN (1) IN163130B (da)
IS (1) IS1448B6 (da)
MA (1) MA20835A1 (da)
NO (1) NO168176C (da)
NZ (1) NZ218675A (da)
OA (1) OA08564A (da)
PH (2) PH24365A (da)
PL (1) PL148408B1 (da)
PT (1) PT83982B (da)
SU (1) SU1496632A3 (da)
TN (1) TNSN86165A1 (da)
YU (1) YU44796B (da)
ZA (1) ZA869560B (da)
ZM (1) ZM10686A1 (da)
ZW (1) ZW24886A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295350B1 (fr) * 1987-06-17 1992-11-11 Laboratoires DELAGRANGE Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US20050140688A1 (en) * 2003-12-29 2005-06-30 Kim Pallister Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR1539104A (fr) * 1967-07-31 1968-09-13 Ile De France Nouveaux benzamides et leur procédé de préparation
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
DE1963193A1 (de) * 1969-12-17 1971-06-24 Bayer Ag N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2905883A1 (de) * 1979-02-16 1980-08-28 Boehringer Sohn Ingelheim Radioimmuntest fuer clonidin
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
US4461904A (en) * 1981-11-20 1984-07-24 Alcon Laboratories, Inc. 2-(Trisubstituted phenylimino)-imidazolines
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6341471A (ja) * 1986-08-08 1988-02-22 Nippon Soda Co Ltd オキサ(チア)ゾリジン誘導体、その製造法及び殺ダニ剤
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

Also Published As

Publication number Publication date
FR2592042B1 (fr) 1988-03-25
GR3002524T3 (en) 1993-01-25
YU44796B (en) 1991-02-28
DK612886A (da) 1987-06-20
NO865148D0 (no) 1986-12-18
CN1018454B (zh) 1992-09-30
HUT43844A (en) 1987-12-28
KR870006008A (ko) 1987-07-08
IL81010A (en) 1991-06-30
IS3178A7 (is) 1987-06-20
IE863270L (en) 1987-06-19
DE3643103A1 (de) 1987-06-25
IE59212B1 (en) 1994-01-26
FI865190A (fi) 1987-06-20
GB2184723A (en) 1987-07-01
YU217986A (en) 1987-12-31
OA08564A (fr) 1988-09-30
ZA869560B (en) 1987-11-25
ZM10686A1 (en) 1987-11-27
US4914117A (en) 1990-04-03
EP0236646A1 (fr) 1987-09-16
IN163130B (da) 1988-08-13
PH24469A (en) 1990-07-18
PT83982B (pt) 1989-01-17
PT83982A (en) 1987-01-01
PH24365A (en) 1990-06-13
AU6668786A (en) 1987-06-25
MA20835A1 (fr) 1987-07-01
KR930004653B1 (ko) 1993-06-02
IS1448B6 (is) 1991-01-16
CS274285B2 (en) 1991-04-11
AR242193A1 (es) 1993-03-31
CS960386A2 (en) 1990-09-12
NO168176C (no) 1992-01-22
CA1299579C (fr) 1992-04-28
CA1298301C (fr) 1992-03-31
PL148408B1 (en) 1989-10-31
CN86108972A (zh) 1987-11-18
FR2592042A1 (fr) 1987-06-26
GB8630143D0 (en) 1987-01-28
EP0236646B1 (fr) 1990-10-10
ES2036178T3 (es) 1993-05-16
JPS62246553A (ja) 1987-10-27
TNSN86165A1 (fr) 1990-01-01
NZ218675A (en) 1990-06-26
NO865148L (no) 1987-06-22
ATE57376T1 (de) 1990-10-15
SU1496632A3 (ru) 1989-07-23
DD260495A5 (de) 1988-09-28
ZW24886A1 (en) 1987-05-13
GB2184723B (en) 1989-12-28
DE3674916D1 (de) 1990-11-15
HU196794B (en) 1989-01-30
NO168176B (no) 1991-10-14
FI865190A0 (fi) 1986-12-18
US4835172A (en) 1989-05-30
CH671396A5 (da) 1989-08-31
PL263078A1 (en) 1988-04-14
AU586057B2 (en) 1989-06-29
IL81010A0 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
DK335686A (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
NO860425L (no) Fremgangsmaate ved fremstilling av nye 11-beta-fenylgonaner
DK154287D0 (da) Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne
NO860371L (no) Fremgangsmaate ved fremstilling av peptidaseinhibitorer.
ES557723A0 (es) Procedimiento para la produccion de tiazoles
IT1190018B (it) Procedimento per la produzione di beta-allumina
DK506386A (da) Flavonderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
NO863139D0 (no) Fremgangsmaate ved fremstilling av nye benzamider.
ZA862747B (en) Intermediates for the production of epipodophyilotoxin and related compounds and processes for the preparation and use thereof
DK416888D0 (da) Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser
DK54787D0 (da) Fremgangsmaade til fremstilling af l-alfa-hydroxyvitamin d forbindelser og mellemprodukter til brug herved
DK354485A (da) 3-substituerede l-aminoalkyl-lh-indol-forbindelser, fremgangsmaader til fremstilling deraf og mellemprodukter til anvendelse derved samt farmaceutiske praeparater
DK612886D0 (da) Substituerede ortho-anisamider, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemidler indeholdende anisamiderne
DK326085A (da) 4-amino-2-phenylquinoliner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
DK579786A (da) Imidazopyridazinalkensyreamider, deres fremstilling og anvendelse samt mellemprodukter til brug ved fremstillingen
DK402685D0 (da) Alfa-glucosidaseinhibitor, dets fremstilling og anvendelse samt farmaceutiske praeparater
DK631386A (da) 1-carbacephalosporin-antibiotika, fremgangsmaade til fremstilling deraf samt mellemprodukter til brug ved fremgangsmaaden
DK439789D0 (da) Ethansulfonamidforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende samme samt mellemprodukter til anvendelse ved fremgangsmaaden
DK439588A (da) Beta-lactamer, fremgangsmaade til deres fremstilling, mellemprodukter til brug derved og farmaceutiske praeparater indeholdende forbindelserne
NO880802L (no) Mellomprodukter og fremgangsmaater til fremstilling av antihyperkolesterolemiske tetrazolforbindelser.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
DK312988D0 (da) Fremgangsmaade til fremstilling af zidovudin samt mellemprodukter ved fremgangsmaaden
DK149787D0 (da) Oxazepamholdigt farmaceutisk middel, fremgangsmaade til fremstilling deraf samt dets anvendelse
DK555288D0 (da) Cephalosporinderivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne og mellemprodukter til anvendelse ved fremgangsmaaden
DK165554C (da) Quinolizin-4-on-forbindelser, fremgangsmaade til fremstilling deraf, praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af praeparaterne samt anvendelse af forbindelserne

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment